ROYAL BANK OF CANADA - GAMIDA CELL LTD ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of GAMIDA CELL LTD
ValueSharesWeighting
Q3 2023$2,0001,803
+5534.4%
0.00%
Q3 2022$032
+3100.0%
0.00%
Q2 2022$01
-87.5%
0.00%
Q1 2022$0
-100.0%
8
-100.0%
0.00%
Q4 2021$42,000
-88.2%
16,776
-81.5%
0.00%
Q3 2021$356,000
-26.0%
90,726
+21.0%
0.00%
Q2 2021$481,000
-15.9%
74,981
+6.1%
0.00%
Q1 2021$572,000
-1.5%
70,650
+1.9%
0.00%
Q4 2020$581,000
+59.2%
69,300
-21.2%
0.00%
Q3 2020$365,000
+36.7%
87,920
+50.4%
0.00%
Q2 2020$267,000
+276.1%
58,450
+320.5%
0.00%
Q2 2019$71,00013,9010.00%
Other shareholders
GAMIDA CELL LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,724,201$6,759,0003.08%
Healthcare Value Capital, LLC 100,000$392,0000.77%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 175,000$686,0000.54%
Laird Norton Wetherby Trust Company, LLC 529,103$2,074,0000.21%
Rock Springs Capital Management LP 2,147,400$8,418,0000.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 107,000$418,0000.10%
Platform Technology Partners 55,875$219,0000.10%
FIRST MIDWEST BANK TRUST DIVISION 139,331$546,0000.08%
Guild Investment Management, Inc. 18,000$71,0000.07%
Virtus ETF Advisers LLC 33,121$130,0000.06%
View complete list of GAMIDA CELL LTD shareholders